Company intelligence
Alveus Therapeutics Inc
Make Weight Loss Last
Biotechnology Research
Philadelphia, US
35 employees
Founded 2023
2 public signals
About Alveus Therapeutics Inc
Alveus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, designed for sustained efficacy, improved tolerability, and reduced treatment burden.
Verified activity
Signals from Alveus Therapeutics Inc
2 published signals
Presence & Recognition
Alveus Therapeutics Inc was named a finalist for Series A Raise of the Year at the 2026 European Lifestars Awards
Reported by Alveus Therapeutics Inc
People
Alveus Therapeutics Inc welcomed John Stubenrauch, PhD, as Chief Technology Officer and Patrick Garibay, PhD, as Chief Development Officer to open a new office in Boston.
Reported by Alveus Therapeutics Inc